XY Capital’s Amgen AMGN Stock Holding History

XY Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-581	Closed	-$181K	–	58
2025 Q1	$181K	Sell	581 -237	-29%	-$70K	0.05%	180
2024 Q4	$213K	Buy	818 +133	+19%	+$39.5K	0.1%	142
2024 Q3	$221K	Buy	+685	New	+$224K	0.08%	83

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

XY Capital's AMGN Position: Q2 2025 in Review

XY Capital sold out of Amgen (AMGN) in Q2 2025, closing a stake of 581 shares — an estimated $181K sold.

XY Capital first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $221K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

XY Capital reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
XY Capital sold 581 Amgen shares in Q2 2025, an estimated $181K.
XY Capital first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
XY Capital's Amgen position peaked at $221K in Q3 2024.
2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on XY Capital's 13F filing for Q2 2025, filed 14 Aug 2025.